Newer blood thinners surpass warfarin for treating seniors with afib and prior stroke
By
Alicia Lasek
Apr 14, 2022
Direct oral anticoagulants are linked to fewer readmissions for stroke and bleeding events when compared with warfarin, investigators say.
Clinical briefs for Friday, Feb. 11
By
Alicia Lasek
Feb 11, 2022
CDC considers updating mask guidance as states drop mandates … Clot-busting stroke drug safe to use in patients taking blood thinners … New questionnaire helps assess elders’ exercise motivation...
Clinician ‘inertia’? Many still favoring warfarin over safer direct-acting anticoagulants
By
Alicia Lasek
Dec 07, 2021
Many clinicians participating in the Medicare Part D program have continued to prescribe warfarin over direct-acting oral anticoagulants, despite evidence that the latter drugs are safer and more effective...
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
Heparin emerging as a lifesaver for moderately ill COVID patients
By
Alicia Lasek
Oct 18, 2021
High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.
Anticoagulants tied to 43 percent lower risk of COVID hospitalization
By
Alicia Lasek
Sep 29, 2021
Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...
Docs miss — or opt to dismiss — signs of pulmonary embolism in dementia patients, study finds
By
Alicia Lasek
Sep 22, 2021
Physicians appear to place lower importance on factors that may lead to diagnosis of pulmonary embolism when evaluating patients with dementia who present with shortness of breath, investigators say.
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Clinical briefs for Friday, Aug. 13
By
Alicia Lasek
Aug 13, 2021
Nursing home limits turnover with straight talk about COVID – and plenty of chances to get jabbed … No new cases of rare blood clots reported after UK restricts COVID vaccine to older adults … CDC...
Blood thinner reduces acute-care stays of COVID-19 patients: study
By
Alicia Lasek
Aug 06, 2021
Moderately ill hospitalized COVID-19 patients who receive a full dose of heparin have less need for mechanical ventilation, and improved chances of leaving the hospital, a new trial has found.